MedTrace Logo

Evaluation of Safety and Performance of the Orbix Breast Lift System

NCT00774059 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-10-12

No results posted yet for this study

Summary

The study is using a new breast lift system to complement a breast-lift operation.

In general there will be recurrence of breast-ptosis after a correcting operation.

With this device we want to minimize this recurrence and provide an "internal bra".

Conditions

  • Breast Ptosis

Interventions

DEVICE

Breast lift system

During a breast operation for ptosis a device is brought into the breast and attached to the ribs, to provide lifting of the breast

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Marjoes MP Schuckman, MD · Maastricht University Hospital

  • Adi Cohen · Orbix medical

Study Design

Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00774059 on ClinicalTrials.gov